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Neurogenic factors and hypertension in renal disease. Hyper- THE ROLE FOR INCREASED SYMPATHETIC
tension in chronic renal failure (CRF) is very common and NERVOUS SYSTEM ACTIVITY
contributes to morbidity and mortality and to the progression
A significant body of evidence indicates that, to a largeof renal disease. The pathogenesis of hypertension in CRF has
been attributed mostly to sodium retention and to activation extent, hypertension in CRF may be due to increased
of the renin-angiotensin-aldosterone system. More recently an activity of the SNS [5–12]. Our studies on 5/6 nephrecto-
abundance of evidence has accumulated to support a role for mized (CRF) rats have provided the most convincing
increased sympathetic nervous system (SNS) activity in the
evidence yet for a role of the SNS in the pathogenesisgenesis of hypertension associated with CRF. Evidence from
of hypertension associated with CRF. The turnover rateour laboratory has also demonstrated that the rise in central
SNS activity is mitigated by increased local expression of nitric and the secretion of norepinephrine (NE) were greater
oxide synthase (NOS)-mRNA and nitric oxide (NO) produc- in the posterior hypothalamic (PH) nuclei of CRF than
tion, and that the upregulation of NO production in the brain control rats. The secretion of NE from the posterioris mediated by IL-1b.
hypothalamus of CRF rats was also greater than control
rats [13]. Micro-injection of a neurotoxin, 6-hydroxy-
dopamine, in the PH nuclei normalized blood pressure
Hypertension is very common in patients with renal
in CRF rats [14].
disease. Approximately 85% of patients with end-stage
To evaluate the mechanisms responsible for the activa-renal disease have hypertension, which is in part respon-
tion of these nuclei in the central nervous system, wesible for the high incidence of cardiovascular events and
tested whether this activation results from impulses gen-deaths in these patients. Hypertension undoubtedly con-
erating in the affected kidney and transmitted to thetributes to the progression of renal disease [1]. Hyperten-
central nervous system. This possibility is supported bysion is the single most important predictor of coronary
evidence that the kidney is richly innervated with barore-artery disease in uremic patients, even more than ciga-
ceptors and chemoreceptors [15–17] as well as renal af-rette smoking or hypertriglyceridemia [2], and treatment
ferent nerves that project directly or indirectly to a num-of hypertension in these patients is difficult and often
ber of areas in the central nervous system that contributeinadequate. Understanding the mechanisms of hyperten-
to blood pressure regulation [18, 19]. Stimulation of renalsion in these patients may help to more adequately treat
receptors by adenosine, urea, or electrical impulses,hypertension in these patients.
evokes reflex increases in sympathetic nerve activity andThe pathogenesis of hypertension in patients with re-
blood pressure [20–22]. Renal afferent impulses play annal disease and in those on maintenance dialysis is multi-
important role in the genesis of hypertension in one-factorial and may vary depending on the underlying renal
kidney one-clip and two-kidney one-clip Goldblatt hy-disease (Table 1). Activation of the renin-angiotensin-
pertension in rats [23], but not in the deoxycorticosteronealdosterone system in conjunction with sodium retention
acetate-salt (DOCA-salt) hypertension in rats, in theand volume expansion have long been recognized as the
one-kidney one-wrap Grollman hypertension in the rat,most important factors [3, 4]. However, clinical experi-
or in the spontaneously hypertensive rat (SHR) [24–27].ence indicates that volume depletion and inhibition of
Renal afferent impulses may also play a role in thethe renin-angiotensin aldosterone system do not neces-
pathogenesis of hypertension in rats with experimentallysarily result in normalization of blood pressure. This
induced chronic renal failure. In these animals, bilateralsuggests that other factors may play a role.
dorsal rhizotomy, at the level T-10 to L-3, prevented the
increase in blood pressure and the progression of renal
disease [28]. This suggests that increased renal sensoryKey words: chronic renal failure, hypertension, sympathetic nervous
system, nitric oxide inputs from the injured kidney to the central nervous
system may contribute to the development of hyperten-Ó 2000 by the International Society of Nephrology
S-2
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Table 1. Factors implicated in the pathogenesis of hypertension in
end-stage renal disease
Sodium and volume excess
The renin-angiotensin-aldosterone system
The sympathetic nervous system
Endothelium-derived vasodepressor substances
Endothelium-derived vasoconstrictor substances
Erythropoietin use
Divalent ions and parathyroid hormone
Atrial natriuretic peptide
Structural changes in the arteries
Pre-existent essential hypertension
Miscellaneous
Anemia
A-V fistula
Vasopressin
Serotonin
Thyroid function
Calcitonin gene-related peptide Fig. 1. Effects of an intrarenal phenol injection on blood pressure
before and after nephrectomy. The line graphs show the levels of blood
pressure before and after the intrarenal injection of 50 mL of 10%
phenol or normal saline (control) in the left kidney. The injection was
performed after the measurement of baseline blood pressure. Thereaf-
ter, blood pressure was measured weekly by the tail cuff method. Aftersion and to the progression of renal disease in CRF rats.
4 weeks, both control rats and rats that had received phenol underwent
There is also convincing evidence that the SNS plays left nephrectomy. *P , 0.01. Values are means 6 SEM. Reproduced
with permission from [35].an important role in the pathogenesis of hypertension
observed in patients with CRF. Converse et al. [12] found
that the rate of SNS discharge directly recorded from
postganglionic sympathetic fibers in the peroneal nerves
cytoplasmic changes within the more superficial cortexwas greater in dialysis patients with their native kidneys
to complete necrosis of both deeper cortical tubular andthan in those with bilateral nephrectomy.
medullary tubular epithelium, replete with sloughing ofThese findings support the notion that increased affer-
the epithelium in the latter area. Peritubular capillariesent nervous inputs from kidneys with renal diseases may
were markedly congested and dilated in the area of thesend signals to integrative sympathetic nuclei in the cen-
medulla affected by this damage. Arteries showed notral nervous system and contribute to the pathogenesis
evidence of thrombosis. Areas of the phenol-treated kid-of hypertension [16, 17, 19, 21, 29–34]. The normalization
neys distant from the area of phenol-induced damageof blood pressure that follows bilateral nephrectomy may
appeared normal. Kidneys from rats that received nor-be largely due to elimination of these afferent impulses.
mal saline showed only a parenchymal defect, corre-Due to extensive amount of scarring, one cannot rule
sponding to the needle track.out the possibility of a contribution of renal insufficiency
The effects of the phenol-induced renal injury are long-to the genesis of hypertension in the 5/6 nephrectomized
lasting [36]. We examined the chronic effects (4 weeks)rat model. To this end, we have developed a new model
of an intrarenal injection of 50 mL of 10% phenol onof neurogenic hypertension in the rat, in which renal
blood pressure and NE secretion from the posterior hy-injury is not associated with alterations of glomerular
pothalamus (Fig. 1). Systolic blood pressure increasedfiltration rate (GFR). Hypertension in this model is
from 128 6 2.1 to 166 6 4.0 mm Hg (P , 0.01) 4 weekscaused by injecting 50 mL of 10% phenol in the lower
after receiving the intrarenal injection of phenol, but itpole of one kidney. This leads to an immediate elevation
did not change in rats that received the vehicle (125 6of NE secretion from the PH and a rise in blood pressure
2.9 and 130 6 1.2 mm Hg) and in rats that were subjected(BP) [35]. Renal denervation prevents the rise in NE
to renal denervation (127 6 3.4 and 124 6 1.0 mm Hg).secretion from the PH and the rise in BP caused by phenol
The secretion of NE from the PH nuclei was greater (P ,injection. Kidneys removed 2 hours after the acute ad-
0.01) in rats that received phenol (253 6 9.6 pg/mL) thanministration of phenol showed an area (1 mm in width),
in controls (158 6 8.6 pg/mL) and denervated rats (170 6which extended from the cortex to the medulla in a
2.1 pg/mL) (Fig. 2). Ablation of the injured kidney ledroughly rectangular configuration. In the center of this
to normalization of blood pressure (128 6 3.7 mm Hg)area there was a parenchymal defect, likely correspond-
and of NE secretion from the PH nuclei in rats injecteding to the needle track, filled with hemorrhage. Glomer-
with phenol (171 6 2.1 vs. 253 6 9.6 pg/mL; P , 0.01).uli in the cortex of the affected area showed intracapil-
The reason(s) for this delayed recovery of BP have notlary congestion and/or thrombosis. The interstitium
been established. This could be due to persistent activa-showed multifocal hemorrhages and edema, and the tu-
bules showed extensive damage, ranging from vacuolar tion of the SNS despite removal of the primary stimulus,
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to a new understanding of the pathophysiology of hyper-
tension in renal disease and, hopefully, to novel therapies
based on specific inhibitors of these activating factors.
The kidney removed 5 weeks after the injection of phe-
nol showed a rather small area of linear scar extending
from the cortex into the superficial medulla. This area
showed tubular atrophy and scarring, with small tubules,
a few of them containing hyaline casts. There was a moder-
ate interstitial chronic inflammation including plasma
cells and pigmented-laden (hemosiderin-laden) macro-
phages as well as scant interstitial fibrosis. Glomeruli,
interstitium, and arteries appeared normal in the regions
adjacent to this area and throughout the rest of the kid-
ney. The kidney of animals injected with vehicle showed
no abnormalities. Serum creatinine did not change after
Fig. 2. Effects of an intrarenal phenol injection on NE secretion from the intrarenal administration of phenol indicating that
the PH nuclei before and after nephrectomy. The bar graphs show the this model of hypertension does not cause any significantsecretion rates of NE from the PH nuclei measured by the microdialysis
change in renal function.technique, in rats that had received an intrarenal injection of phenol,
in rats that had undergone left nephrectomy (Nx) 2 weeks prior to the
measurements and 6 weeks after the injection of phenol (Phenol 1
Nx), and in control rats that had received an intrarenal injection of THE ROLE FOR NITRIC OXIDE
saline. *P , 0.01. Values are means 6 SEM. Reproduced with permis-
sion from [35]. Recent studies have provided evidence that nitric ox-
ide synthase (NOS) is present in specific area of the brain
involved in the neurogenic control of blood pressure
[38, 39]. The neuroneal isoform of NO synthase (nNOS)
to slow regression of adaptive vascular changes, or to is an important component of the transduction pathways
slow return to normal of renal homeostatic responses to that tonically inhibit the sympathetic outflow from the
changes in BP. brain stem [40]. In normal rats, the basal activity of the
In the phenol-renal injury model, the increase in NE central sympathetic nervous system is regulated by local
secretion from the PH is primary and not secondary to NO production. Evidence in our laboratory also indi-
the rise in BP, since when BP is raised by intravenous cates that the expression of neuroneal NOS is increased
administration of angiotensin II, NE secretion from the in the brain of CRF rats compared with control rats and
PH diminishes rather than increasing. The effect of phe- this may serve to attenuate the rise in sympathetic nerve
nol is specific to the kidney, since injections of phenol firing [41].
in the peritoneal cavity or in the spleen does not cause These studies do not preclude nor are against the pos-
any sustained elevation of BP. The unique features of sibility that peripheral NO production may be reduced
this model are that hypertension occurs in the face of in CRF and that this may contribute to rising blood
minimal renal injury (1 3 2 mm wide), and without pressure [42].
perturbation of GFR [14]. Moreover, the effects of phe-
nol appear to be specific for this compound, since renal
INTERRELATIONS BETWEEN CYTOKINESlesions of the same magnitude caused by burning, admin-
AND SYMPATHETIC NERVE ACTIVITYistration of alkali (NaOH), acids (HCl), or methanol
IN UREMIAcause no elevation of BP. The potential importance of
this observation is substantial, since clinical experience Complex relationships exist between cytokines, sym-
indicates that not all renal diseases (injuries) in humans pathetic nervous system and nitric oxide. Interleukin-1b
are associated with hypertension. For example, in the (IL-1b) has modulatory actions on the central and pe-
absence of renal insufficiency, IgA nephropathy is more ripheral sympathetic nervous system [43–46] Substantial
likely to be associated with hypertension than membra- evidence indicates that IL-1b activates NOS expression
nous glomerulonephritis or minimal change disease [37]. in several organs [47, 48] including smooth muscle and
These studies have demonstrated for the first time that endothelial cells [49, 50]. NO is involved in the IL-1b
a specific injury to a limited portion of one kidney may induced central activation of sympathetic outflow in rats
cause a permanent elevation of BP in the rat. Hyperten- [51]. We have evaluated the effects of an injection of
sion in this model is mediated by neurogenic mecha- IL-1b in the lateral ventricle on BP, on NE secretion
nisms. Identification of the factor(s) responsible for the from the PH, and on nNOS-mRNA expression in several
brain nuclei of Sprague-Dawley rats. IL-1b caused a dose-intrarenal activation of these afferent pathways may lead
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